← Back to Search

TopSpin360 Device for Neck Strength and Brain Function Improvement

N/A

Recruiting

Led By Michael Stuart, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-season (approximately 6 months)

Awards & highlights

Study Summary

This trial will test a new neck strengthening device to see if it increases neck strength and brain function.

Who is the study for?

This trial is for healthy individuals who are medically cleared to play ice hockey and can speak English fluently. It's not suitable for those with pacemakers, hearing issues, skull implants, seizure history, or allergies to rubbing alcohol or EEG gel.Check my eligibility

What is being tested?

The study is examining the TopSpin360 training device to see if it improves neck strength and cognitive function in participants who are active ice hockey players.See study design

What are the potential side effects?

Since this trial involves a physical training device rather than medication, side effects may include muscle soreness or strain from using the TopSpin360 equipment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-season (approximately 6 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-season (approximately 6 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-season (approximately 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in N100 Amplitude

Change in N100 Latency

Change in N400 Amplitude

+10 more

Secondary outcome measures

Change in King-Devick Test (KDT) scores

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TopSpin360 Intervention GroupExperimental Treatment1 Intervention

Subjects will use TopSpin360, twice- weekly and use for the duration of the hockey season.

Group II: Control GroupActive Control1 Intervention

Subjects will receive no intervention for the duration of the hockey season.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,216 Previous Clinical Trials

3,767,428 Total Patients Enrolled

Michael Stuart, MDPrincipal InvestigatorMayo Clinic

3 Previous Clinical Trials

4,121 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this experimental protocol open to seniors aged 70 and up?

"According to the clinical trial guidelines, prospective participants must be between 18 and 21 years old."

Answered by AI

How many volunteers have participated in this clinical trial?

"Indeed, the details available on clinicaltrials.gov signify that this trial is actively recruiting subjects. The original posting date was September 9th 2023 and it has been recently updated on 22nd of the same month. There are 60 participants needed to be enrolled from a single site."

Answered by AI

What criteria must be met for a person to be eligible for enrollment in this trial?

"The requirements to join this clinical trial are simple; prospective participants must be healthy and aged between 18-21. Currently, 60 people are being sought for enrolment."

Answered by AI

Are participants recruiting for this trial at the present time?

"Affirmative. As per clinicaltrials.gov, this medical trial commenced on the 9th of September 2023 and is still actively recruiting participants. In total 60 patients are required for the one location hosting it."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study of TopSpin360 Training Device

Michael J. Stuart MD 2023. "A Study of TopSpin360 Training Device". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06052553.